639 related articles for article (PubMed ID: 24325852)
1. Pharmacophore mapping-based virtual screening followed by molecular docking studies in search of potential acetylcholinesterase inhibitors as anti-Alzheimer's agents.
Ambure P; Kar S; Roy K
Biosystems; 2014 Feb; 116():10-20. PubMed ID: 24325852
[TBL] [Abstract][Full Text] [Related]
2. Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer's Disease.
Son M; Park C; Rampogu S; Zeb A; Lee KW
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823604
[TBL] [Abstract][Full Text] [Related]
3. Use of ligand-based pharmacophore modeling and docking approach to find novel acetylcholinesterase inhibitors for treating Alzheimer's.
Dhanjal JK; Sharma S; Grover A; Das A
Biomed Pharmacother; 2015 Apr; 71():146-52. PubMed ID: 25960230
[TBL] [Abstract][Full Text] [Related]
4. Pharmacophore Modeling, virtual and in vitro screening for acetylcholinesterase inhibitors and their effects on amyloid-β self- assembly.
Bag S; Tulsan R; Sood A; Datta S; Török M
Curr Comput Aided Drug Des; 2013 Mar; 9(1):2-14. PubMed ID: 22734711
[TBL] [Abstract][Full Text] [Related]
5. Acetylcholinesterase inhibitors: structure based design, synthesis, pharmacophore modeling, and virtual screening.
Valasani KR; Chaney MO; Day VW; Shidu Yan S
J Chem Inf Model; 2013 Aug; 53(8):2033-46. PubMed ID: 23777291
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches.
Pang X; Fu H; Yang S; Wang L; Liu AL; Wu S; Du GH
Molecules; 2017 Jul; 22(8):. PubMed ID: 28933746
[TBL] [Abstract][Full Text] [Related]
7. Virtual screening, molecular interaction field, molecular dynamics, docking, density functional, and ADMET properties of novel AChE inhibitors in Alzheimer's disease.
da Silva CH; Carvalho I; Taft CA
J Biomol Struct Dyn; 2007 Jun; 24(6):515-24. PubMed ID: 17508773
[TBL] [Abstract][Full Text] [Related]
8. Combined 3D-QSAR, molecular docking, and molecular dynamics study of tacrine derivatives as potential acetylcholinesterase (AChE) inhibitors of Alzheimer's disease.
Zhou A; Hu J; Wang L; Zhong G; Pan J; Wu Z; Hui A
J Mol Model; 2015 Oct; 21(10):277. PubMed ID: 26438408
[TBL] [Abstract][Full Text] [Related]
9. Pharmacophore-based drug design of AChE and BChE dual inhibitors as potential anti-Alzheimer's disease agents.
Gao H; Jiang Y; Zhan J; Sun Y
Bioorg Chem; 2021 Sep; 114():105149. PubMed ID: 34252860
[TBL] [Abstract][Full Text] [Related]
10. In silico Structure-based Identification of Novel Acetylcholinesterase Inhibitors Against Alzheimer's Disease.
Iman K; Mirza MU; Mazhar N; Vanmeert M; Irshad I; Kamal MA
CNS Neurol Disord Drug Targets; 2018 Apr; 17(1):54-68. PubMed ID: 29336270
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a novel acetylcholinesterase inhibitor by structure-based virtual screening techniques.
Chen Y; Fang L; Peng S; Liao H; Lehmann J; Zhang Y
Bioorg Med Chem Lett; 2012 May; 22(9):3181-7. PubMed ID: 22472693
[TBL] [Abstract][Full Text] [Related]
12. Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer's Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches.
Ojo OA; Ojo AB; Okolie C; Nwakama MC; Iyobhebhe M; Evbuomwan IO; Nwonuma CO; Maimako RF; Adegboyega AE; Taiwo OA; Alsharif KF; Batiha GE
Molecules; 2021 Apr; 26(7):. PubMed ID: 33915968
[TBL] [Abstract][Full Text] [Related]
13. Pharmacophore-based drug design for potential AChE inhibitors from Traditional Chinese Medicine Database.
Jiang Y; Gao H
Bioorg Chem; 2018 Feb; 76():400-414. PubMed ID: 29258018
[TBL] [Abstract][Full Text] [Related]
14. Identification of molecular descriptors for design of novel Isoalloxazine derivatives as potential Acetylcholinesterase inhibitors against Alzheimer's disease.
Gurung AB; Aguan K; Mitra S; Bhattacharjee A
J Biomol Struct Dyn; 2017 Jun; 35(8):1729-1742. PubMed ID: 27410776
[TBL] [Abstract][Full Text] [Related]
15. Prediction of Anti-Alzheimer's Activity of Flavonoids Targeting Acetylcholinesterase in silico.
Das S; Laskar MA; Sarker SD; Choudhury MD; Choudhury PR; Mitra A; Jamil S; Lathiff SMA; Abdullah SA; Basar N; Nahar L; Talukdar AD
Phytochem Anal; 2017 Jul; 28(4):324-331. PubMed ID: 28168765
[TBL] [Abstract][Full Text] [Related]
16. In silico identification of AChE and PARP-1 dual-targeted inhibitors of Alzheimer's disease.
Hu XM; Dong W; Cui ZW; Gao CZ; Yu ZJ; Yuan Q; Min ZL
J Mol Model; 2018 Jun; 24(7):151. PubMed ID: 29869722
[TBL] [Abstract][Full Text] [Related]
17. Identification of potential bivalent inhibitors from natural compounds for acetylcholinesterase through in silico screening using multiple pharmacophores.
Lakshmi V; Kannan VS; Boopathy R
J Mol Graph Model; 2013 Mar; 40():72-9. PubMed ID: 23353586
[TBL] [Abstract][Full Text] [Related]
18. Construction of the pharmacophore model of acetylcholinesterase inhibitor.
Zhu Y; Tong XY; Zhao Y; Chen H; Jiang FC
Yao Xue Xue Bao; 2008 Mar; 43(3):267-76. PubMed ID: 18630262
[TBL] [Abstract][Full Text] [Related]
19. Quantifying ligand-receptor interactions for gorge-spanning acetylcholinesterase inhibitors for the treatment of Alzheimer's disease.
Martis EA; Chandarana RC; Shaikh MS; Ambre PK; D'Souza JS; Iyer KR; Coutinho EC; Nandan SR; Pissurlenkar RR
J Biomol Struct Dyn; 2015; 33(5):1107-25. PubMed ID: 24905476
[TBL] [Abstract][Full Text] [Related]
20. Discovery of new multifunctional selective acetylcholinesterase inhibitors: structure-based virtual screening and biological evaluation.
Jiang CS; Ge YX; Cheng ZQ; Song JL; Wang YY; Zhu K; Zhang H
J Comput Aided Mol Des; 2019 May; 33(5):521-530. PubMed ID: 30989573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
